Models
DR. REDDY S LABORATORIESDRREDDYPharmaceuticals & Biotechnology
441per share · Base Model Note
Revenue growth, the horizon and scenarios are yours to change. Every other input is part of the Trader plan; saving, sharing a saved link and the live-formula workbook are part of the Institutional plan.
Scenario
Value per share, your model441implied FY26 P/E 11.4× · EV/EBITDA 6.4×
Against CMP ₹1,165.5062.2%close of 2026-09-10
Growth the CMP implies45.0%revenue, a year for 5 years, on your other inputs
Value after FY3173%share of enterprise value in the terminal
This figure is the arithmetic of your inputs and nothing else. MarketPing publishes no fair value, target or rating; the model is yours.

Where the methods land · ₹ per share · the dashed line is the CMP

DCF, rate ±1 · growth ±1your model across the sensitivity grid
332657
52-week rangetraded range, a fact not a value
1,1011,415

From enterprise to equity · ₹ crore

PV of FY27FY31 free cash flow11,044
PV of terminal value30,500
Enterprise value41,544
less net debt(4,757)
less non-controlling interest0
add non-operating investments0
Equity value36,787
÷ 83.50 crore shares441

Free cash flow, filed and modelled · ₹ '000 crore

012345FY21: ₹2,596 croreFY21FY22: ₹1,345 croreFY22FY23: ₹4,755 croreFY23FY24: ₹2,903 croreFY24FY25: ₹1,892 croreFY25FY26: ₹3,343 croreFY26FY27: ₹2,755 croreFY27FY28: ₹2,800 croreFY28FY29: ₹2,846 croreFY29FY30: ₹2,891 croreFY30FY31: ₹2,937 croreFY31
Filed, cash from operations − capexModelled free cash flow to firm

Sensitivity · ₹ per share

Down Across
WACCterminal growth4.0%4.5%5.0%5.5%6.0%
10.00%457493537590657
10.50%418449484527580
11.00%385411441476518
11.50%357379404433467
12.00%332351372396425
The outlined cell is your model. Green figures sit above the CMP of ₹1,165.50; n/a marks a terminal growth at or above the discount rate. Steps: WACC and terminal growth ±0.5 point, growth ±2, margin ±1.

Distribution of outcomes · 4,000 draws · growth, margin and the discount rate vary together

P10330P50438P90556
10th · 50th · 90th percentile, ₹ per share330 · 438 · 556
Draws below the CMP100%
Rank correlation with ebitda margin+0.85
Rank correlation with discount rate0.49
Rank correlation with revenue growth0.05
Each driver is drawn from a PERT distribution between the lowest and highest value across your scenarios (or ±50% growth, ±20% margin when there is one scenario), with the discount rate ±1.5 points. Seeded, so the same inputs give the same picture.

Projected cash flow to the firm · ₹ crore

History Forward
₹ croreFY23FY24FY25FY26FY27FY28FY29FY30FY31
Revenue24,67028,01132,64433,70034,71135,75336,82537,93039,068
growth %14.513.516.53.23.03.03.03.03.0
EBITDA6,3497,9338,5476,4546,6306,8297,0347,2457,462
margin %25.728.326.219.119.119.119.119.119.1
less depreciation(1,250)(1,470)(1,704)(2,059)(2,117)(2,181)(2,246)(2,314)(2,383)
EBIT5,0996,4636,8434,3954,5124,6484,7874,9315,079
less tax on EBIT(1,011)(1,038)(1,069)(1,101)(1,134)(1,168)
NOPAT3,3843,4753,5793,6863,7973,911
add depreciation1,2501,4701,7042,0592,1172,1812,2462,3142,383
less capex(1,132)(1,640)(2,750)(2,331)(2,395)(2,504)(2,618)(2,737)(2,860)
less working-capital build(442)(455)(469)(483)(497)
Free cash flow to firm4,7552,9031,8922,7552,8002,8462,8912,937
Discount factor0.9490.8550.7700.6940.625
Present value2,6152,3942,1922,0061,836
History columns are the filed years (free cash flow there is cash from operations − capex, as filed); the base year and everything to its right come from the engine. Forward is the explicit horizon of the model itself: 3, 5 or 10 years, then flat.

The three statements, projected · ₹ crore · debt held at 6,294, dividends at 15.9% of profit

₹ croreFY26FY27FY28FY29FY30FY31
Income statement
EBIT4,3954,5124,6484,7874,9315,079
Interest at 7.1% on debt(447)(447)(447)(447)(447)
Profit before tax4,0664,2014,3404,4844,632
Profit after tax4,1963,1313,2353,3423,4533,567
Dividends(666)(498)(514)(531)(549)(567)
Balance sheet, year end
Cash1,5373,4505,3927,3629,36011,386
Working capital14,73615,17815,63316,10116,58417,081
Net block and other assets41,85142,12942,45242,82443,24743,724
Debt6,2946,2946,2946,2946,2946,294
Equity38,23140,86443,58446,39549,29952,298
Balance check000000
Cash flow
From operations4,8064,9615,1205,2845,452
Investing (capex)(2,395)(2,504)(2,618)(2,737)(2,860)
Financing (dividends)(498)(514)(531)(549)(567)
Net change in cash1,9131,9421,9701,9982,026
Free cash flow to equity2,4112,4562,5012,5472,593
Other liabilities are held at their FY26 level, so the check tests only what the model moves: cash, working capital, net block and other assets, debt and equity. A non-zero check would mean the three statements no longer tie.

Scenarios side by side · ₹ per share

ScenarioTemplateGrowthMarginRateTerminal₹ / sharevs CMP
Base · editingDCF3%19.1%11.00%5%441(62.2)%
A scenario is a full set of inputs under a name. Keep Base as the filed history carried forward; add Bull and Bear by saving the current inputs under those names and moving the two or three assumptions you actually hold a view on. The distribution above draws each driver between the lowest and highest value across your scenarios, so three scenarios give it a real range; with one scenario it falls back to fixed bands.